P. Rao et al. / Tetrahedron Letters 53 (2012) 5314–5317
5317
Table 2 (continued)
Entry
Diketonea
Aminea
Aldehydea
Product
Time (h)
Yieldb (%)
O
CHO
O
O
O
O
O
Cl
N
H
10b
3c
79
75
OH
O
OH
Cl
HN
CHO
O
NO2
N
H
10c
3c
OH
OH
NO2
HN
a
The reactions were conducted with aldehyde (1 mmol), 4-hydroxy coumarin/1,3-dimedone (1 mmol), secondary amine (1 mmol), and InCl3 (10 mol %) in toluene at room
temperature.
b
c
Isolated yields.
Reaction carried out at reflux temperatures.
3. (a) Patil, A. D.; Freyer, A. J.; Eggleston, D. S.; Haltiwanger, R. C.; Bean, M. F.;
Taylor, P. B.; Caranfa, M. J.; Breen, A. L.; Bartus, H. R.; Johnson, R. K.; Hertzberg,
R. P.; Westley, J. W. J. Med. Chem. 1993, 36, 4131; (b) Guilet, D.; Hélesbeux, J.-J.;
Séraphin, D.; Sévenet, T.; Richomme, P.; Bruneton, J. J. Nat. Prod. 2001, 64, 563.
4. (a) Hadler, M. R.; Shadbolt, R. S. Nature 1975, 253, 275; (b) Takumi, M.; Ikuzo,
N.; Tsuneaki, H.; Akiya, K.; Kambe, N.; Sonoda, N. Synthesis 1988, 257; (c)
Angelo, C.; Ombretta, P. Synthesis 1993, 99; (d) Fiedler, V. B.; Scholtholt, J.
Pharmacol. Exp. Ther. 1981, 217, 306.
5. (a) Babu, G.; Perumal, P. T. Aldrichim. Acta 2000, 33, 16; (b) Ghosh, R. Indian J.
Chem. 2001, 40B, 550; (c) Clarke, P. A.; Zaytzev, A. V.; Whitwood, A. C.
Tetrahedron Lett. 2007, 48, 5209; (d) Shanthi, G.; Perumal, P. T. Tetrahedron Lett.
2009, 50, 3959; (e) Shanthi, G.; Perumal, P. T. Tetrahedron Lett. 2008, 49, 7139;
(f) Yadav, J. S.; Reddy, B. V. S.; Satheesh, G.; Narasimhulu, G.; Portier, Y.;
Madhavi, C.; Kunwar, A. C. Tetrahedron Lett. 2008, 49, 3341; (g) Kumar, R.;
Nandi, G. C.; Verma, R. K.; Singh, M. S. Tetrahedron Lett. 2010, 51, 442.
6. Mulakayala, N.; Kandagatla, B.; Ismail; Rapolu, R. K.; Rao, P.; Mulakayala, C.;
Kumar, C. S.; Iqbal, J.; Oruganti, S. Bioorg. Med. Chem. Lett. 2012, 22, 5063.
7. Kumar, A.; Gupta, M. K.; Kumar, M. Tetrahedron Lett. 2011, 52, 4521.
8. Ghosh, P. P.; Das, A. R. Tetrahedron Lett. 2012, 53, 3140.
(Table 2). All the products 8a–m were characterized and confirmed
by 1H NMR, 13C NMR, and mass.1H NMR spectra of the compounds
8h–m showed a characteristic singlet at around d 5.01 indicating
that the products exist exclusively in their enol forms.10
Interestingly, reactions of 4-hydroxy coumarin with indole and
aromatic aldehydes furnished product 10a–c (Scheme 2, and Ta-
ble 2), wherein the most acidic C-3 proton of indole was involved.
Compound 10 is obtained via a conjugate addition product of the
enone formed from 4-hydroxy coumarin and aromatic aldehyde
with indole (Fig. 3).
In summary, we have developed a convenient methodology for
the synthesis of
via a three-component reaction using InCl3 catalyst. This reaction
has been extended to -benzylamino diketone derivatives and rep-
a-benzylamino coumarin derivatives in high yields
a
resents a mild and convenient route.
9. General experimental procedure: To a solution of aldehyde (1 mmol), 4-hydroxy
coumarin (1 mmol), and InCl3 (0.1 mmol) in anhydrous toluene (4 mL),
secondary amine (1 mmol) was added and the reaction mixture was
vigorously stirred at room temperature for 3 h. After the starting materials
disappeared (by TLC) the reaction mixture was quenched by water extracted
with dichloromethane (2 Â 10 mL), dried over anhydrous sodium sulfate.
Evaporation of the solvent under reduced pressure furnished the crude residue
which was triturated in hexane to afford desired product in 80–90% yield.
Acknowledgement
The authors thank the Institute of Life Sciences for its support.
S.K. thanks UGC, New Delhi, for the award of research fellowship.
10. Compound 8a: m.p: 170–172 °C; 1H NMR (400 MHz, CDCl3):
d 7.97 (d,
Supplementary data
J = 7.99 Hz, 1H), 7.64 (d, J = 8.35 Hz, 2H), 7.49–7.44 (m, 1H), 7.31 (d,
J = 8.41 Hz, 2H), 7.23 (d, J = 8.45 Hz, 3H), 5.15 (s, 1H), 3.68–3.62 (m, 1H),
3.18–3.07 (m, 2H), 2.72–2.64 (m, 1H), 2.10–2.0 (m, 4H); 13C NMR (100 MHz,
CDCl3): d 195.4, 167.2, 151.0, 148.5, 143.9, 127.1, 126.3, 125.7, 124.1, 124.1,
123.9, 123.4, 122.7, 122.2, 111.6, 105.5, 60.0, 50.7, 32.7, 30.6; IR (KBr): 3068,
1657, 1456 cmÀ1; ESI (M+): 321.9. Compound 8h: M.P: 132–134 °C; 1H NMR
(400 MHz, CDCl3): d 7.55 (d, J = 6.4 Hz, 2H), 7.32–7.28 (m, 3H), 5.07 (s, 1H),
3.53–3.44 (m, 1H), 2.96–2.90 (m, 2H), 2.57–2.47 (m, 1H), 2.25–2.17 (m, 4H),
2.05–1.87 (m, 4H), 0.99 (s, 6H); 13C NMR (100 MHz, CDCl3): d 174.6, 162.7,
139.2, 129.2, 128.8, 128.2, 127.6, 110.0, 107.6, 69.6, 68.7 (2C), 49.2, 32.4 (2C),
Supplementary data associated with this article can be found, in
the
online
version,
at
References and notes
28.6(2C), 23.8, 23.3; IR (KBr): 2952, 1749, 1417 cmÀ1 ESI (M++1): 300.
;
1. (a) Terret, N. K.; Gardner, M.; Gordon, D. W.; Kobylecki, R. J.; Steele, J.
Tetrahedron 1995, 51, 8135; (b) Armstrong, R. W.; Combs, A. P.; Tempest, P. A.;
Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123; (c) Ramón, D. J.; Yus,
M. Angew. Chem., Int. Ed. 2005, 44, 1602; (d) Dömling, A. Chem. Rev. 2006, 106,
17.
2. (a) Murray, R. D. H. Nat. Prod. Rep. 1995, 12, 477; (b) Estévez-Braun, A.;
González, A. G. Nat. Prod. Rep. 1997, 14, 465; (c) Lacy, A.; O’Kennedy, R. Curr.
Pharm. Des. 2004, 10, 3797.
Compound 10a: m.p: 110–112 °C; 1H NMR (400 MHz, CDCl3): d 7.91 (brs, 1H),
7.41–7.33 (m, 6H), 7.29 (d, J = 7.16 Hz, 1H), 7.23–7.14 (m, 3H), 6.99 (dd,
J = 11.06, 3.97 Hz, 2H), 6.66 (d, J = 1.40 Hz, 2H), 5.89 (s, 1H); 13C NMR
(100 MHz, CDCl3): d 189.4, 167.8, 144.0, 136.6, 132.4, 128.9, 128.4, 128.4,
127.9, 127.0, 126.3, 125.9, 123.7, 123.5, 122.0, 121.6, 120.1, 119.6, 119.3, 119.0,
111.2, 110.8, 68.2, 40.0; IR (KBr): 3413, 1721, 1454 cmÀ1; ESI (M+): 367.9.